Dr. Jun Yang, St. Jude Children's Research Hospital (IMAGE)
Caption
St. Jude Children's Research Hospital scientists have linked inherited variations in a second gene to reduced tolerance of a key cancer drug. Jun J. Yang, Ph.D., is an assistant member of the Department of Pharmaceutical Sciences at St. Jude and is first and corresponding author of the new study.
Credit
Peter Barta, St. Jude Children's Research Hospital
Usage Restrictions
None
License
Licensed content